Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in children with cyclosporine-dependent idiopathic nephrotic syndrome
2009-018266-35Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of rituximab in Idiopathic nephrotic syndrome (INS) and Cyclosporine-dependent nephrotic syndrome (CDNS), sponsored by CHU de Limoges. Started Jun 2010; status: completed.
02
Drugs
rituximab
03
Conditions
Idiopathic nephrotic syndrome (INS)Cyclosporine-dependent nephrotic syndrome (CDNS)
Beyond the preview
Go deeper on 2009-018266-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018266-35.